Mersana Therapeutics Inc
MRSN
Market Cap$315.69M
Close$
$-1.04
138.1% downside
Current Fair Value
138.1% downsideOvervalued by 138.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $315.69 Million |
|---|---|
| Enterprise Value | $165.62 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.13 |
| Beta | 1.48 |
| Outstanding Shares | 122,361,236 |
| Avg 30 Day Volume | 1,935,402 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.34 |
|---|---|
| PEG | 3.57 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 4.32 |
| Enterprise Value to EBIT | -1.23 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.2 |
| Debt to Equity | 1.18 |
Revenue Sources
No data
ESG Score
No data
About Mersana Therapeutics Inc
CEO: Anna Protopapas